Research on Clinical Effect of Calcitonin Combined with Alendronate in the Treatment of Osteoporosis  

在线阅读下载全文

作  者:HEXiuli JINXinglin 

机构地区:[1] Guizhou Orthopaedic Hospital, Guiyang 550000, China [2] Guiyang People's Hospital of Nanming District, Guiyang 550000, China

出  处:《外文科技期刊数据库(文摘版)医药卫生》2022年第5期197-200,共4页

摘  要:Objective: to explore the effect of combined application of calcitonin and alendronate in the clinical treatment of osteoporosis. Methods: this article collected and selected 60 patients with osteoporosis who were admitted to the department of orthopedics in our hospital from November 2020 to October 2021, and randomly divided the experimental patients into a control group (30 cases) and a research group (30 cases). The control group was treated with calcitonin drugs, and the study group was treated with a moderate amount of alendronate on the basis of the control group, and the changes in bone mineral density, biochemical indicators, incidence of adverse reactions, and incidence of adverse reactions were compared between the two groups before and after treatment. Clinical treatment effect. Results: after statistical study, there was no special difference in bone mineral density between the study group and the control group before treatment (P > 0.05). After treatment, the bone mineral density of femur (0.91 ± 0.05) and lumbar spine (0.97 ± 0.26) in the study group were higher than those in the control group (0.72 ± 0.08), (0.83 ± 0.24);The relevant biochemical indexes in the study group were better than those in the control group;The overall incidence of nausea, vomiting, constipation, fever and other adverse reactions in the study group was 13.3%, which had no special difference from 23.3% in the control group (P > 0.05);The clinical therapeutic effect of the study group was 96.7%, which was higher than 80.0% of the control group. The specific difference between the two groups was statistically significant (P < 0.05). Conclusion: in the clinical treatment of patients with osteoporosis, the combined use of calcitonin and alendronate has a very significant effect. These two drugs can alleviate the symptoms of patients, increase the overall bone density of patients, and promote their body-related biochemical indicators. Early recovery can improve the quality of daily life while maintaining their health and saf

关 键 词:OSTEOPOROSIS CALCITONIN ALENDRONATE clinical application effect 

分 类 号:R[医药卫生]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象